Craig Fairchild

2.2k total citations
24 papers, 743 citations indexed

About

Craig Fairchild is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Craig Fairchild has authored 24 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Organic Chemistry and 6 papers in Molecular Biology. Recurrent topics in Craig Fairchild's work include Cancer Treatment and Pharmacology (18 papers), Synthetic Organic Chemistry Methods (10 papers) and Microbial Natural Products and Biosynthesis (5 papers). Craig Fairchild is often cited by papers focused on Cancer Treatment and Pharmacology (18 papers), Synthetic Organic Chemistry Methods (10 papers) and Microbial Natural Products and Biosynthesis (5 papers). Craig Fairchild collaborates with scholars based in United States, Germany and Switzerland. Craig Fairchild's co-authors include Vittorio Farina, Tai W. Wong, Fei Huang, Karen A. Reeves, Suso Platero, Edwin Clark, Francis Lee, Peter Shaw, Xia Han and Byron H. Long and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Craig Fairchild

24 papers receiving 719 citations

Peers

Craig Fairchild

ONCOL

Hong Chang United States

Linda James United Kingdom

Oksana Nemirovsky Canada

Susan Ashwell United States

Joseph J. Catino United Kingdom

Somhairle MacCormick United Kingdom

Giacomo Cossa Italy

Elena Porcù Italy

Gisela Claassen United States

Roberta Pireddu United States

Hong Chang United States

Craig Fairchild

346 ×0.7

ONCOL

463 ×1.3

121 ×0.6

60 ×0.5

118 ×1.2

Citations per year, relative to Craig Fairchild Craig Fairchild (= 1×) peers Hong Chang

Countries citing papers authored by Craig Fairchild

Since Specialization

Citations

This map shows the geographic impact of Craig Fairchild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Fairchild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Fairchild more than expected).

Fields of papers citing papers by Craig Fairchild

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Fairchild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Fairchild. The network helps show where Craig Fairchild may publish in the future.

Co-authorship network of co-authors of Craig Fairchild

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Fairchild. A scholar is included among the top collaborators of Craig Fairchild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Fairchild. Craig Fairchild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kirov, Stefan, Heshani Desilva, Jian Cao, et al.. (2015). Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene Expression. Molecular Cancer Therapeutics. 14(10). 2167–2174. 72 indexed citations

Talbott, Randy, R. M. Borzilleri, Charu Chaudhry, et al.. (2015). Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport. Experimental Cell Research. 338(2). 251–260. 3 indexed citations

Huang, Fei, Chang Han, Ann Greer, et al.. (2014). IRS2 Copy Number Gain, KRAS and BRAF Mutation Status as Predictive Biomarkers for Response to the IGF-1R/IR Inhibitor BMS-754807 in Colorectal Cancer Cell Lines. Molecular Cancer Therapeutics. 14(2). 620–630. 25 indexed citations

Huang, Fei, Karen A. Reeves, Xia Han, et al.. (2007). Identification of Candidate Molecular Markers Predicting Sensitivity in Solid Tumors to Dasatinib: Rationale for Patient Selection. Cancer Research. 67(5). 2226–2238. 274 indexed citations

Clark, Edwin, Karen A. Reeves, Xiaojun Han, et al.. (2005). Identification of pharmacogenomic markers for predicting sensitivity to BMS-354825, a SRC/ABL kinase inhibitor. Journal of Clinical Oncology. 23(16_suppl). 3010–3010. 2 indexed citations

Rose, William C., Craig Fairchild, & Francis Y. F. Lee. (2001). Preclinical antitumor activity of two novel taxanes. Cancer Chemotherapy and Pharmacology. 47(2). 97–105. 40 indexed citations

Yuan, Haiqing, David G. I. Kingston, Byron H. Long, Craig Fairchild, & Kathy Johnston. (1999). Synthesis and biological evaluation of C-1 and ring modified A-norpaclitaxels. Tetrahedron. 55(30). 9089–9100. 4 indexed citations

Chordia, Mahendra D., David G. I. Kingston, Ernest Hamel, et al.. (1997). Synthesis and biological activity of A-nor-paclitaxel analogues. Bioorganic & Medicinal Chemistry. 5(5). 941–947. 12 indexed citations

Chen, Shuhui, Stella Huang, Byron H. Long, et al.. (1997). Structure-activity relationships study at the 3′-N position of paclitaxel-part 1: Synthesis and biological evaluation of the 3′-(t)-butylaminocarbonyloxy bearing paclitaxel analogs. Bioorganic & Medicinal Chemistry Letters. 7(23). 3057–3062. 5 indexed citations

10.

Liang, Xian, David G. I. Kingston, Byron H. Long, Craig Fairchild, & Kathy Johnston. (1997). Paclitaxel analogs modified in ring C: Synthesis and biological evaluation. Tetrahedron. 53(10). 3441–3456. 20 indexed citations

11.

Kant, Joydeep, Craig Fairchild, Qi Gao, et al.. (1996). Diastereoselective addition of Grignard reagents to azetidine-2,3-dione: Synthesis of novel Taxol® analogues. Tetrahedron Letters. 37(36). 6495–6498. 48 indexed citations

12.

Long, B H, Craig Fairchild, Joan M. Carboni, et al.. (1996). ChemInform Abstract: Novel C‐4 Paclitaxel (Taxol) Analogues: Potent Antitumor Agents. ChemInform. 27(12). 1 indexed citations

13.

Fairchild, Craig, et al.. (1995). Synthesis and Biological Evaluation of Novel C-4 Aziridine-Bearing Paclitaxel (Taxol) Analogs. Journal of Medicinal Chemistry. 38(12). 2263–2267. 10 indexed citations

14.

Liang, Xian, David G. I. Kingston, Byron H. Long, Craig Fairchild, & Kathy Johnston. (1995). Synthesis, structure elucidation and biological evaluation of C-norpaclitaxel. Tetrahedron Letters. 36(43). 7795–7798. 10 indexed citations

15.

Chen, Shuhui, Joydeep Kant, Stephen W. Mamber, et al.. (1994). Taxol® structure-activity relationships: synthesis and biological evaluation of taxol analogs modified at C-7. Bioorganic & Medicinal Chemistry Letters. 4(18). 2223–2228. 15 indexed citations

16.

Kant, Joydeep, Vittorio Farina, Craig Fairchild, et al.. (1994). Synthesis and antitumor properties of novel 14-β-hydroxytaxol and related analogues. Bioorganic & Medicinal Chemistry Letters. 4(13). 1565–1570. 6 indexed citations

17.

Chen, Shu Hui, Stella Huang, Joydeep Kant, et al.. (1993). Synthesis of 7-deoxy- and 7,10-dideoxytaxol via radical intermediates. The Journal of Organic Chemistry. 58(19). 5028–5029. 42 indexed citations

18.

Chen, Shu Hui, Craig Fairchild, Stephen W. Mamber, & Vittorio Farina. (1993). Taxol structure-activity relationships: synthesis and biological evaluation of 10-deoxytaxol. The Journal of Organic Chemistry. 58(11). 2927–2928. 27 indexed citations

19.

Kant, Joydeep, Stella Huang, Henry Ν. C. Wong, et al.. (1993). Studies toward structure-activity relationships of taxol®: synthesis and cytotoxicity of taxol® analogues with C-2′ modified phenylisoserine side chains. Bioorganic & Medicinal Chemistry Letters. 3(11). 2471–2474. 41 indexed citations

20.

Smaldone, Laurie, Patricia M. Plezia, David S. Alberts, et al.. (1990). Batanopride (BMY-25801): A new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis. Cancer Treatment Reviews. 17(2-3). 319–327. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact